Lupin

Lupin gets tentative nod from US FDA to market generic Brexpiprazole tablets

Read more

Lupin launches Droxidopa capsules in US

Read more

US FDA issues Form 483 to Lupin’s Goa plant

Read more

Lupin launches authorised generic version of Duexis in US

Read more

Redefining job roles to build competitive compliance

Read more

TB Alliance and Lupin partner to manufacture anti-TB drug pretomanid

Read more

Lupin launches Luforbec 100/6 μg pMDI

Read more

Lupin receives tentative US FDA approval for Brivaracetam tablets

Read more

Lupin launches Tavaborole Topical Solution in US

Read more

Lupin gets tentative US FDA nod for Dolutegravir, Lamivudine and Tenofovir Disoproxil Fumarate (TLD) tablets under PEPFAR

Read more